Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The D-alanyl-D-alanine (D-Ala-D-Ala) terminus is a critical structural motif found on the pentapeptide side chains of peptidoglycan precursors, such as Lipid II, in Gram-positive bacteria like Streptococcus pneumoniae (StatPearls, 2023). This dipeptide serves as the essential substrate for transpeptidase enzymes, also known as penicillin-binding proteins, which catalyze the cross-linking of peptidoglycan layers to maintain the structural integrity of the bacterial cell wall (Nature Reviews Microbiology, 2006). Glycopeptide antibiotics, including vancomycin and teicoplanin, exert their bactericidal effect by binding with high affinity to the D-Ala-D-Ala terminus through a network of five hydrogen bonds (PubMed, PMID: 16921300). This interaction creates a steric cap that blocks the enzymes responsible for polymerizing and cross-linking the cell wall, leading to osmotic instability and cell death (Journal of Biological Chemistry, 2008). Because this target is located on the exterior of the cytoplasmic membrane, it is highly accessible to drugs, though therapeutic challenges include the emergence of resistance through the modification of the terminus to D-alanyl-D-lactate (StatPearls, 2023).
Glycopeptide antibiotics bind to the D-Ala-D-Ala terminus of peptidoglycan precursors via hydrogen bonding, sterically hindering the transglycosylation and transpeptidation reactions required for cell wall assembly.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-alanyl-D-alanine (D-Ala-D-Ala) terminus of peptidoglycan precursors (D-Ala-D-Ala).